FDA Clearance Tracker · P150026-S011
HeartLight Catheter and HeartLight Console
Last checked: Nov 20, 2026Latest source record: Jul 1, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jul 1, 2020
Approved
Time to decision
30 days
Received Jun 1, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150026-S011
- Device name
- HeartLight Catheter and HeartLight Console
- Applicant
- Cardiofocus, Inc.
- Applicant location
- Marlborough, MA
- Received
- Jun 1, 2020
- Decided
- Jul 1, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P150026
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Cardiofocus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150026 · Decided Apr 1, 2016 · 246 days after receipt
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.